“…The corpus callosum is strongly implicated in a variety of sex-linked genetic disorders including supernumerary sex chromosome aneuploidies (Wade et al, 2014) and Fragile X syndrome (Villalon-Reina et al, 2013), as well as many other complex neuropsychiatric disorders ranging from major depressive disorder (Ballmaier et al, 2008), bipolar disorder (Fears et al, 2014) and schizophrenia (Narr et al, 2000, Kochunov et al, 2014), to various types of dementia (Daianu et al, 2015), and many others. Not only is it implicated in these numerous diseases with sex differences in their prevalence, it is also highly genetically influenced (Bearden et al, 2011, Jahanshad et al, 2013, Kochunov et al, 2016). More practically, unlike some other structures with widely reported structural and functional sex differences, like the amygdala (Hamann, 2005), the corpus callosum is simple to extract and measure from many modalities of neuroimaging; given the controversy in findings, a structure that is easier and more reliable to measure (Morey et al, 2010) might be a good target to analyze, and methodological errors in its measurement are perhaps less likely to influence the reported sex differences.…”